5 August 2026
GLP-1 weight loss drugs have changed who is booking filler consultations at UK clinics: patients who have lost weight quickly are increasingly presenting with hollow cheeks, sunken temples and looser skin, a pattern nicknamed Ozempic face. The priority for injectors is to ask about weight loss medication early, treat in stages rather than all at once, and set expectations that the plan may need revisiting if the patient's weight keeps changing. Around 1.6 million adults in England, Wales and Scotland used a GLP-1 medicine for weight loss between early 2024 and early 2025, according to a University College London study published in BMC Medicine, and public searches for Ozempic face have risen sharply since 2021 as the aesthetic effects of rapid weight loss have become better known.
What Ozempic face actually looks like
The term describes facial fat pad deflation and skin laxity that follows rapid, significant weight loss, whether triggered by a GLP-1 medicine or not. Patients typically present with sunken cheeks, hollow temples, deeper nasolabial folds and looser skin around the jaw, on a face that has usually kept a fuller shape for years. Facial fat pads shrink along with fat elsewhere in the body, but skin often does not retract at the same speed, particularly in older patients. Clinical trials of GLP-1 medicines rarely record facial fat loss as a side effect, so the accredited register Save Face has warned that many patients arrive at a filler consultation without connecting the two.
Why more of these patients are reaching the treatment chair
A University College London study published in BMC Medicine in January 2026 put GLP-1 use for weight loss at around 1.6 million adults across England, Wales and Scotland between early 2024 and early 2025, with a further 3.3 million saying they would consider it. A separate analysis in the Journal of Cosmetic Dermatology found that public search interest in Ozempic face rose roughly 4,600 percent between 2021 and 2024, tracking closely with prescribing volumes. The industry is seeing the same shift in its own numbers: on 23 July 2026, Galderma told investors that demand for its filler and Sculptra ranges was being boosted by patients seeking to soften the facial sagging that follows rapid weight loss.
What to ask before you plan treatment
Save Face's guidance for practitioners is to ask directly whether a patient requesting filler is using, or has recently stopped, a weight loss medicine, since the answer changes both the assessment and the conversation about how long results will last. Harley Academy's clinical guidance adds a further question: whether the patient has reached their target weight or is still losing, because starting injectables mid loss risks hollowing out an area that has only just been filled. A patient still losing weight is not a stable canvas, and one who has recently stopped may be heading for weight regain that leaves earlier filler looking overdone.
Treating in stages, and knowing when not to
Both Harley Academy and a case report in The PMFA Journal describe a staged approach for this patient group: skin quality and laxity addressed first, then volume restored gradually with neuromodulators, biostimulators or filler across several sessions rather than correcting everything at once. Not every patient in this group is a good candidate for filler alone. Where skin laxity is advanced, adding volume can make an area look heavier rather than more youthful, and energy based skin tightening or a surgical opinion may serve the patient better. Whatever the plan, it should be reviewed if the patient's weight changes again, and that conversation is best had, and recorded, before the first session.
Common questions
What is Ozempic face?
It is the informal term for facial fat loss and skin laxity that can follow rapid weight loss, including weight lost on GLP-1 medicines such as Ozempic, Wegovy or Mounjaro, typically showing as hollow cheeks, sunken temples and looser skin around the jaw.
Should I ask patients if they are taking weight loss medication before treating them?
Yes. UK guidance from Save Face and Harley Academy both recommend asking directly, because current or recent GLP-1 use changes the treatment plan, the timing, and how long results are likely to hold.
What treatments help with facial volume loss after weight loss?
Practitioners commonly combine skin quality treatments, neuromodulators, biostimulators and volumising filler in stages rather than all at once, though patients with advanced skin laxity may be better served by skin tightening or a surgical referral.
Where Sulaia helps
The practitioner workspace
One calendar, one home, across every clinic you visit.
See how it works